Abstract
Radiotherapy is the usual treatment for inoperable esophageal carcinoma. Results published before 1976, when this trial was begun were very modest, except for those of Pearson [1], The 1-year survival rate varies from 15% to 30%, and 5-year survival rates were about 5% [2–7].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Pearson JG (1971) The value of radiotherapy in the management of squamous esophageal cancer. Br J Surg 58: 794–798
Roussel A (1975) Bilan des cancers de l’oesophage traites au centre Francois Baclesse depuis 1964. Ouest Med 28 (6): 381–386
Verhaege M, Rohart J, Adenis L, Demaille A, Lequint A, Vankemel B, Delloitte M (1971) Possibilites et resultats de la radiotherapie dans les cancers de l’oesophage (a propos de 300 cas en 10 ans). Presse Med 79: 236
Pierquin B, Wanbersie A, Tubiana M (1966) Cancer of thoracic oesophagus: two series of patients treated by 22 mv betatron. Br J Radiol 39: 189–192
Marcial VA, Tome JM, Ubinas J, Bosh A, Correa JN (1966) Esophageal cancer: the role of radiation therapy. Radiology 87: 231–239
Lederman M (1966) Carcinoma of esophagus with special reference to upper third. Part I. Clinical considerations. Br J Radiol 39: 193–197
Leborgne R, Leborgne F, Bartocci L (1963) Cancer of the esophagus: results of radiotherapy. Br J Radiol 36: 806–811
Kolaric K et al. (1976) Therapy of advanced oesophageal cancer with bleomycin, irradiation and combination of bleomycin with irradiation. Tumori 62 (3): 255–262
Okamoto T et al. (1972) Systemic chemotherapy of esophageal cancer. Jpn J Cancer Clin [Suppl]: 370–374
Soga J, Fujimaki M, Kawaguchi M et al. (1971) Bleomycin and irradiation effects on the esophageal carcinoma: a preliminary historical evaluation. Acta Med Biol 19 (2): 119–136
Robillard J, Couedic Y (1967) Resultats compares de 80 cas de cancers de l’oesophage traites soit par telecobalt soit par association telecobalt-methylhydrazine. J Radiol Elec-trol 48: 867–871
Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457–481
Mantel N (1966) Evaluation of survival data and two new rank order statistics arising into consideration. Cancer Chemother Rep 50: 163–170
Earlam R, Cunha-Melo JR (1980) Oesophageal squamous cell carcinoma. II. A critical review of radiotherapy. Br J Surg 67: 457–461
Roussel A (1979) Le pronostic du cancer de l’oesophage. Gaz Med France 86 (37): 4361–4369
Belghiti J, Langonnet F, Wessely JY, Fekete F (1981) Faut-il corriger la denutrition des malades ayant un cancer de l’oesophage ou du cardia en periode pre-operatoire? Nouv Presse Med 10(27): 2273–2279
Paillot B, Bodenes P, Czervichow P (1985) Facteurs pronostiques des cancers epider-moides de l’oesophage. Gastroenterol Clin Biol 9(2b): 68A
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Roussel, A. et al. (1988). Controlled Clinical Trial for the Treatment of Patients with Inoperable Esophageal Carcinoma: A Study of the EORTC Gastrointestinal Tract Cancer Cooperative Group. In: Schlag, P., Hohenberger, P., Metzger, U. (eds) Combined Modality Therapy of Gastrointestinal Tract Cancer. Recent Results in Cancer Research, vol 110. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83293-2_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-83293-2_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-83295-6
Online ISBN: 978-3-642-83293-2
eBook Packages: Springer Book Archive